Press release
Global Advanced Liver Cancer Market Projected to Surpass $3.78 Billion by 2029 with 14.8% Annual Growth
Advanced Liver Cancer Market Size
The upward trend in long-term hepatitis infections is set to foster the development of the advanced liver cancer market in the future. Long-term hepatitis infections, which are persistent viral infections that last for over six months, can lead to liver damage, cirrhosis, and liver cancer. The rise in these long-term hepatitis infections owes to elements such as insufficient screening and vaccination measures, as well as hindered access to timely treatment. Chronic hepatitis B (HBV) or hepatitis C (HCV) infections constitute some of the primary precursors to liver cirrhosis and hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. These long-lasting viral infections can cause liver inflammation, liver damage, and eventually cancer over an extended period. With their widespread occurrence, the number of individuals liable to develop advanced liver cancer is increasing. For example, in April 2024, the Switzerland-based intergovernmental organization World Health Organization highlighted that in 2022 chronic hepatitis B affected 254 million people globally with 1.2 million new cases each year. Consequently, the surging prevalence of long-term hepatitis infections is propelling the expansion of the advanced liver cancer market.
Get Your Advanced Liver Cancer Market Report Here:
https://www.thebusinessresearchcompany.com/report/advanced-liver-cancer--global-market-report
How will the growth rate of the advanced liver cancer market shape industry trends by 2034?
In recent years, the market size for advanced liver cancer has seen a quick expansion. The market is forecasted to surge from $1.89 billion in 2024 to $2.17 billion in 2025 with a compound annual growth rate (CAGR) of 15.2%. The growth witnessed during the historical period is primarily due to rising awareness about liver cancer, an escalating number of patients, an increased need for targeted treatments, enhanced healthcare infrastructure, and a growing preference for minimally invasive procedures.
Experts predict a swift enlargement of the advanced liver cancer market in the immediate future, with an estimated projected worth of $3.78 billion by the year 2029 and a compound annual growth rate of 14.8%. Various factors contribute to this anticipated growth, such as the escalating number of liver cancer incidence, enhanced healthcare expenditure, a rise in the occurrence of genetic conditions, growing reliance on precision medicine, and increased usage of screening and diagnostic tests. Some prevalent trends to watch for within this period are artificial intelligence's usage in treatment plans, the proliferation of innovative drugs and therapies, increased research and development endeavors, advances in targeted therapeutics, and surging demand for personalized medicine.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20706&type=smp
What trends are poised to drive the future success of the advanced liver cancer market?
Leading enterprises in the advanced liver cancer market are intent on developing novel drugs such as human monoclonal antibodies. These strategies are tailored to enhance treatment effectiveness and reduce adverse effects, leading to improved patient recovery. A human monoclonal antibody is a laboratory-engineered molecule designed to emulate the body's immune system's role in battling harmful pathogens or cancerous cells. It zeroes in on specific antigens found on the surface of these detrimental bodies to provoke an immune retaliation. For example, in October 2022, AstraZeneca, a pharmaceutical conglomerate based in the US, publicized that the US Food Drug Administration (FDA) bestowed approval to Imjudo (tremelimumab) to be administered in combination with Imfinzi (durvalumab) for adult patients suffering from unresectable hepatocellular carcinoma (HCC), which is the most prevalent variety of liver cancer. This sanction was given following the encouraging results from the HIMALAYA Phase III trial, which affirmed that this combined treatment lessened the mortality risk by 22% in comparison to sorafenib. Remarkably, about 31% of the patients survived after three years in contrast to the 20% survival rate amongst those treated with sorafenib. Known as the STRIDE regimen, it comprises an initial dose of Imjudo succeeded by regular administrations of Imfinzi every four weeks. This presents a novel treatment alternative for patients who have minimal options at their disposal.
Which primary segments of the advanced liver cancer market are driving growth and industry transformations?
The advanced liver cancer market covered in this report is segmented -
1) By Test Type: Imaging Test, Biopsy, Genomic Test, Other Test Types
2) By Technology: Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluoroimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, Other Technologies
3) By Distribution Channel: Direct Tenders, Retail Sales, Other Distribution Channel
4) By Application: Screening, Diagnostic And Predictive, Prognostic, Research
5) By End-User: Hospitals, Cancer Research Centers, Academic Institutes, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Imaging Test: Ultrasound, CT (Computed Tomography) Scan, MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography) Scan
2) By Biopsy: Needle Biopsy, Laparoscopic Biopsy, Surgical Biopsy
3) By Genomic Test: Next-Generation Sequencing (NGS), PCR (Polymerase Chain Reaction) Testing, Genetic Mutation Profiling
4) By Other Test Types: Serum Biomarker Testing, Liver Function Tests, Alpha-Fetoprotein (AFP) Test, Elastography Tests
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20706
Which geographical regions are pioneering growth in the advanced liver cancer market?
North America was the largest region in the advanced liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced liver cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the advanced liver cancer market landscape?
Major companies operating in the advanced liver cancer market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Stryker Corporation, Agilent Technologies Inc., Eisai Co. Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd, Exelixis Inc., Sirtex Medical Limited, Eureka Therapeutics, Abbisko Therapeutics Co. Ltd., Binhui Biopharmaceutical Co. Ltd., Tempest Therapeutics Inc., Auransa Inc., Mina Alpha Limited, Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20706&type=smp
What Is Covered In The Advanced Liver Cancer Global Market Report?
•Market Size Forecast: Examine the advanced liver cancer market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the advanced liver cancer market for a structured understanding.
•Key Players Overview: Analyze major players in the advanced liver cancer market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the advanced liver cancer market.
•Segment Contributions: Evaluate how different segments drive overall growth in the advanced liver cancer market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the advanced liver cancer market.
•Industry Challenges: Identify potential risks and obstacles affecting the advanced liver cancer market.
•Competitive Landscape: Review strategic developments in the advanced liver cancer market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Advanced Liver Cancer Market Projected to Surpass $3.78 Billion by 2029 with 14.8% Annual Growth here
News-ID: 3944632 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Test
Key Differences Between Megger Test, Tan Delta Test, and Hi-Pot Test for Electri …
Electrical insulation plays a critical role in ensuring the safety and efficiency of electrical systems. To assess the condition of insulation and identify potential issues, three common tests are used: the Megger test, Tan Delta test, and Hi-Pot test. Each test serves a unique purpose and provides valuable insights into the state of electrical insulation. Here's a closer look at the differences between these three essential tests.
Megger Test: Insulation Resistance…
Vitamin Test Market: Global Vitamin Test Analysis and Forecast (2023-2029)Vitami …
12.04.2024: Vitamin Test Market Overview
The development of companion diagnostic tools and advances in personalised treatment are driving considerable growth and revolution in the oncology Vitamin Test market. In the era of precision medicine, where healthcare is increasingly customised for individual individuals based on their own genetic and molecular profiles, this market segment is essential. Ongoing innovation and development define the oncology Vitamin Test market. To find particular biomarkers, genetic mutations,…
CAGR 8.1% Homecare Pregnancy Test Kits Market By Type of Test (Urine Test For H …
The Homecare Pregnancy Test Kits market report by Reports and Data provides an extensive overview of the vital elements of the Homecare Pregnancy Test Kits market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and others. Further, it mentions the market shares associated with the market in terms of both value and volume along with the segmentation. Space-age industrial and digitalization tools are…
Home Safety Test Kits Market, Home Safety Test Kits Market Trends, Home Safety T …
“Home Safety Test Kits Market” 2020-2025 Research Report is a professional and in-depth study on the current state of the market. Global Home Safety Test Kits market containing a complete view of the market size, business share, profit estimates, SWOT analysis and the regional landscape of the Industry. The report explains key challenges and future development prospects of the market. The Global Home Safety Test Kits analysis is provided for…
Test Data Management (TDM) Market - test data profiling, test data planning, tes …
The report categorizes the global Test Data Management (TDM) market by top players/brands, region, type, end user, market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
This report studies the global market size of Test Data Management (TDM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption…
Hearing Screening and Diagnostic Devices Market Demands with Major Tests: pure T …
New Market Research Reports Title "Hearing Screening And Diagnostic Devices Market 2018" Has Been Added to Crystal Market Research Report database.
Hearing Screening and Diagnostic Devices - Competitive Insights:
The leading players in the market are Gn Otometrics A/S, Otodynamics, Nashua Hearing Group, Siemens Healthineers, Natus Medical Incorporated, Interacoustics A/S, Neurosoft S.A, Accent Hearing Pty Ltd, MAICO Diagnostics GmbH and IntriCon Corporation. The major players in the market are profiled in detail…
